Content will continue after the ad
Advertising
–
The decision was made on the basis of individual reports European Union thromboembolic events and similar events observed at different times after vaccination.
At the same time, SPCC, IVP, ZVA and VI emphasize that to date there are no data on the causal link between vaccination and serious health problems. The decision to suspend vaccination with AstraZeneca for up to two weeks has only been taken as a precautionary measure until information on the causal assessment of the cases reported so far has been received.
The European Medicines Agency (EMA) is still evaluating the information received on the possible causal relationship of AstraZeneca to thromboembolic events and considers that the benefits of vaccination with AstraZeneca against Covid-19 outweigh the potential health risks. However, several EU Member States (Germany, Denmark, the Netherlands, Italy, Norway, France, Bulgaria, Ireland, Iceland) have suspended vaccination with AstraZeneca while the reported cases are being evaluated.
It should also be borne in mind that health problems, including thromboembolic events, can be observed in the general population for a variety of reasons, regardless of the use of herbs or vaccination, as their causes may vary, recalls the ZVA.
To date, no report has been approved in Latvia in which the reported medical conditions are similar to those reported in other European Union countries in relation to the thromboembolic signal, which is currently being reviewed by the ESA Safety Committee (PRAC). Information on adverse drug reaction reports of Covid-19 vaccines received by the State Agency of Medicines is regularly published on the website of the State Agency of Medicines.
Following the recommendation to temporarily suspend vaccination against Covid-19 with AstraZeneca, vaccination offices are advised not to use already opened vaccine vials or to start new ones.
Healthcare authorities say there is no cause for concern for people who have been vaccinated with AstraZeneca so far. If you feel unwell after getting vaccinated for more than 1-3 days after receiving the vaccine or if you experience other health problems, you should contact your family doctor.
The Latvian authorities will provide further information on the outcome of the evaluation.
It has been reported that the Health Inspectorate and the State Agency of Medicines have already temporarily suspended the use of one batch of vaccine developed by AstraZeneca in Latvia on March 9, 2021, which Latvia received on February 11.
–
